| Health-related quality of life in Parkinson’s disease: a cross-sectional study focusing on non-motor symptoms L Kadastik-Eerme, M Rosenthal, T Paju, M Muldmaa, P Taba Health and quality of life outcomes 13, 1-8, 2015 | 154 | 2015 |
| Differences in MDS‐UPDRS scores based on Hoehn and Yahr stage and disease duration M Skorvanek, P Martinez‐Martin, N Kovacs, M Rodriguez‐Violante, ... Movement disorders clinical practice 4 (4), 536-544, 2017 | 113 | 2017 |
| Relationship between the MDS-UPDRS and quality of life: a large multicenter study of 3206 patients M Skorvanek, P Martinez-Martin, N Kovacs, I Zezula, ... Parkinsonism & related disorders 52, 83-89, 2018 | 71 | 2018 |
| Nonmotor features in Parkinson’s disease: what are the most important associated factors? L Kadastik-Eerme, M Muldmaa, S Lilles, M Rosenthal, N Taba, P Taba Parkinson’s Disease 2016 (1), 4370674, 2016 | 43 | 2016 |
| Looking beyond the brain to improve the pathogenic understanding of Parkinson’s disease: implications of whole transcriptome profiling of Patients’ skin A Planken, L Kurvits, E Reimann, L Kadastik-Eerme, K Kingo, S Kõks, ... BMC neurology 17, 1-11, 2017 | 40 | 2017 |
| Increased serum levels of mesencephalic astrocyte-derived neurotrophic factor in subjects with Parkinson’s disease E Galli, A Planken, L Kadastik-Eerme, M Saarma, P Taba, P Lindholm Frontiers in Neuroscience 13, 929, 2019 | 33 | 2019 |
| Factors associated with motor complications in Parkinson's disease L Kadastik‐Eerme, N Taba, T Asser, P Taba Brain and behavior 7 (10), e00837, 2017 | 28 | 2017 |
| Transcriptomic profiles in Parkinson’s disease L Kurvits, F Lättekivi, E Reimann, L Kadastik-Eerme, KM Kasterpalu, ... Experimental Biology and Medicine 246 (5), 584-595, 2021 | 27 | 2021 |
| Biallelic variants in TSPOAP1, encoding the active-zone protein RIMBP1, cause autosomal recessive dystonia NE Mencacci, MM Brockmann, J Dai, S Pajusalu, B Atasu, J Campos, ... The Journal of Clinical Investigation 131 (7), 2021 | 23 | 2021 |
| Saliva changes in Parkinson’s disease patients after injection of Botulinum neurotoxin type A J Tiigimäe-Saar, T Tamme, M Rosenthal, L Kadastik-Eerme, P Taba Neurological Sciences 39, 871-877, 2018 | 23 | 2018 |
| The increasing prevalence of Parkinson's disease in Estonia L Kadastik‐Eerme, N Taba, T Asser, P Taba Acta Neurologica Scandinavica 138 (3), 251-258, 2018 | 20 | 2018 |
| Analysis of repetitive element expression in the blood and skin of patients with Parkinson’s disease identifies differential expression of satellite elements KJ Billingsley, F Lättekivi, A Planken, E Reimann, L Kurvits, ... Scientific Reports 9 (1), 4369, 2019 | 18 | 2019 |
| Adapting the Sniffin'Sticks olfactory test to diagnose Parkinson's disease in Estonia E Antsov, L Silveira-Moriyama, S Kilk, L Kadastik-Eerme, T Toomsoo, ... Parkinsonism & related disorders 20 (8), 830-833, 2014 | 17 | 2014 |
| Incidence and mortality of Parkinson’s disease in Estonia L Kadastik-Eerme, N Taba, T Asser, P Taba Neuroepidemiology 53 (1-2), 63-72, 2019 | 13 | 2019 |
| Substantia nigra hyperechogenicity: Validation of transcranial sonography for Parkinson disease diagnosis in a large Estonian cohort T Toomsoo, I Liepelt-Scarfone, R Kerner, L Kadastik-Eerme, T Asser, ... Journal of Ultrasound in Medicine 35 (1), 17-23, 2016 | 13 | 2016 |
| Effect of age on substantia nigra hyper-echogenicity in Parkinson's disease patients and healthy controls T Toomsoo, I Liepelt-Scarfone, D Berg, R Kerner, AH Pool, ... Ultrasound in medicine & biology 45 (1), 122-128, 2019 | 12 | 2019 |
| Prevalence of depressive symptoms and their association with brainstem raphe echogenicity in patients with Parkinson's disease and non-PD controls T Toomsoo, R Randver, I Liepelt-Scarfone, L Kadastik-Eerme, T Asser, ... Psychiatry Research: Neuroimaging 268, 45-49, 2017 | 10 | 2017 |
| Parkinson’s disease in Estonia: epidemiology, quality of life, clinical characteristics and pharmacotherapy L Kadastik-Eerme Tartu, 2019 | 7 | 2019 |
| Lack of accredited clinical training in movement disorders in Europe, Egypt, and Tunisia G Tamás, M Fabbri, C Falup-Pecurariu, T Teodoro, MM Kurtis, R Aliyev, ... Journal of Parkinson's disease 10 (4), 1833-1843, 2020 | 5 | 2020 |
| Serum amyloid alpha is downregulated in peripheral tissues of Parkinson’s disease patients L Kurvits, E Reimann, L Kadastik-Eerme, L Truu, K Kingo, T Erm, S Kõks, ... Frontiers in Neuroscience 13, 13, 2019 | 5 | 2019 |
